GLOW

GLOW Overview

The GLOW Blend combines three synthetic peptides studied for their roles in molecular signaling and pathway dynamics: GHK-Cu, BPC-157, and TB-500. Together, these peptides are investigated for their influence on angiogenesis, extracellular matrix remodeling, and systemic signaling pathways. In laboratory and preclinical models, the combination provides a platform for exploring synergistic effects in matrix integrity, vascular formation, and molecular resilience. Pickart L. et al. (2015)

History

The concept of the GLOW Blend arises from decades of research into individual signaling peptides. GHK-Cu was first identified in biological plasma samples in the 1970s and later studied for gene regulation and matrix remodeling activity. BPC-157 was synthesized in the 1990s as a gastric protein fragment analog and has since been researched for angiogenic and structural processes. TB-500, derived from thymosin beta-4, traces its research lineage to thymus peptide studies in the 1960s and is recognized for its effects on molecular migration and angiogenesis. Combined, these peptides represent a convergence of experimental research lines. Sikiric P. et al. (1993)

GLOW Structure

CAS #:

49557-75-7

Molecular Formula:

C₁₄H₂₄CuN₆O₄

Molecular Weight:

340.9 g/mol

PubChem ID:

5311476